Search

Search Constraints

You searched for: Author/Creator Tojima, Hiroki

Search Results

1. A case of unresectable combined hepatocellular and cholangiocarcinoma treated with atezolizumab plus bevacizumab. Issue 7 (25th July 2022)

3. Analyses of objective response rate, progression‐free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study. Issue 3 (10th December 2019)

5. Changes of esophageal varices in hepatitis C patients after achievement of a sustained viral response by direct‐acting antivirals. Issue 1 (5th July 2021)

7. Effect of 48‐week pemafibrate on non‐alcoholic fatty liver disease with hypertriglyceridemia, as evaluated by the FibroScan‐aspartate aminotransferase score. Issue 10 (28th August 2021)

8. Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma. Issue 9 (11th December 2014)

9. Factors predicting overall response and overall survival in hepatocellular carcinoma patients undergoing balloon‐occluded transcatheter arterial chemoembolization: A retrospective cohort study. Issue 2 (22nd June 2017)

10. Favorable outcome of retreatment by direct‐acting antivirals for hepatitis C patients with daclatasvir plus asunaprevir combination therapy failure. Issue 3 (19th December 2019)